DEA Schedule CII

Strength

1.25; 1.25; 1.25; 1.25 mg/1; mg/1; mg/1; mg/1

NDC

00228306211

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Last Updated

4/22/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA077302

On Market Since

6/22/2012

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation

Price History

1W

0.0%

1M

-0.4%

3M

+17.1%

6M

+1.3%

1Y

-10.1%

3Y

-33.7%

5Y

-38.5%

All

-88.3%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.